fr

Successful first “Aeson® European User Meeting”, marking an important step in the deployment of CARMAT’s artificial heart

Update on the PIVOTAL study on the CARMAT bioprosthetic artificial heart

Download

2016 half-year results

Download

Stéphane Piat has been appointed CEO of CARMAT

Download

CARMAT announces the departure of Marcello Conviti, CEO

Download

CARMAT announces the start of the PIVOTAL study

Download

CARMAT has obtained the necessary approvals to begin the PIVOTAL study in France

Download

Extraordinary General Meeting of August 10, 2016

Download

CARMAT has begun, with DEKRA, the CE certification process for its bioprosthetic artificial heart

Download
Top of page